We goal to demonstrate early improvement of the medical core list of outcomes and avoidance of medical worsening, and early negativity of SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) among the ambulatory patients with moderate COVID-19 by treating them with Doxycycline and Rivaroxaban compared to patients who receive Hydroxyc… Read More